TD Ameritrade (AMTD) Gets $52.0 Target By Credit Suisse; Hill-rom Holdings Has 1.16 Sentiment

Among 18 analysts covering TD Ameritrade (NYSE:AMTD), 8 have Buy rating, 1 Sell and 9 Hold. Therefore 44% are positive. TD Ameritrade has $60.5 highest and $31.50 lowest target. $49.47’s average target is -9.23% below currents $54.5 stock price. TD Ameritrade had 69 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Nomura with “Buy” on Thursday, July 13. The stock has “Hold” rating by Jefferies on Monday, June 27. The rating was initiated by Morgan Stanley with “Equal-Weight” on Monday, September 26. The firm earned “Hold” rating on Wednesday, January 10 by Keefe Bruyette & Woods. The stock of TD Ameritrade Holding Corporation (NASDAQ:AMTD) has “Buy” rating given on Wednesday, March 23 by SunTrust. Jefferies maintained the stock with “Hold” rating in Thursday, July 20 report. The rating was maintained by Compass Point with “Neutral” on Tuesday, July 21. SunTrust maintained TD Ameritrade Holding Corporation (NASDAQ:AMTD) on Tuesday, October 24 with “Buy” rating. Deutsche Bank maintained TD Ameritrade Holding Corporation (NASDAQ:AMTD) on Wednesday, October 25 with “Hold” rating. On Monday, November 13 the stock rating was upgraded by Deutsche Bank to “Buy”.

Hill-Rom Holdings, Inc. operates as a medical technology firm worldwide. The company has market cap of $5.71 billion. It provides medical surgical beds, intensive care unit beds, bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, communications technologies and software solutions, and health care furniture; and medical equipment management services, as well as sells equipment service contracts for its capital equipment. It has a 43.61 P/E ratio. The firm also offers patient monitoring and diagnostics products, such as blood pressure, physical assessment, vital signs monitoring, diagnostic cardiopulmonary, diabetic retinopathy screening, and thermometry products; and respiratory health products, including Vest, VitalCough, and MetaNeb systems to assist patients in the mobilization of retained blockages.

Investors sentiment increased to 1.09 in 2017 Q3. Its up 0.04, from 1.05 in 2017Q2. It is positive, as 27 investors sold TD Ameritrade Holding Corporation shares while 81 reduced holdings. 35 funds opened positions while 83 raised stakes. 485.17 million shares or 1.58% more from 477.60 million shares in 2017Q2 were reported. Prudential Fin invested in 17,616 shares. Fruth Investment reported 12,250 shares. Atlantic Trust Gp Limited Liability Co invested in 291,230 shares. 6,539 are held by Global X Management Ltd Liability Corporation. Bank Of Montreal Can owns 464,903 shares for 0.02% of their portfolio. Jennison Lc accumulated 0.1% or 1.94 million shares. Hsbc Plc has 87,967 shares. Meiji Yasuda Asset stated it has 0.03% of its portfolio in TD Ameritrade Holding Corporation (NASDAQ:AMTD). Thrivent Financial For Lutherans has 0.06% invested in TD Ameritrade Holding Corporation (NASDAQ:AMTD). Rwc Asset Mngmt Ltd Liability Partnership stated it has 1.89% of its portfolio in TD Ameritrade Holding Corporation (NASDAQ:AMTD). Us Commercial Bank De reported 43,799 shares stake. Andra Ap holds 0.04% or 38,300 shares. Covington Cap Mgmt accumulated 0% or 900 shares. Geode Mgmt Ltd Liability Corporation holds 0.04% or 2.44 million shares. Bp Public Ltd Co, a United Kingdom-based fund reported 30,000 shares.

Analysts await TD Ameritrade Holding Corporation (NASDAQ:AMTD) to report earnings on January, 17. They expect $0.48 earnings per share, up 17.07% or $0.07 from last year’s $0.41 per share. AMTD’s profit will be $272.13 million for 28.39 P/E if the $0.48 EPS becomes a reality. After $0.49 actual earnings per share reported by TD Ameritrade Holding Corporation for the previous quarter, Wall Street now forecasts -2.04% negative EPS growth.

The stock increased 1.41% or $0.76 during the last trading session, reaching $54.5. About 1.84 million shares traded. TD Ameritrade Holding Corporation (NYSE:AMTD) has risen 21.10% since January 13, 2017 and is uptrending. It has outperformed by 4.40% the S&P500.

TD Ameritrade Holding Corporation provides securities brokerage services and related technology financial services to retail investors, traders, and independent registered investment advisors in the United States. The company has market cap of $30.90 billion. The Company’s services and products include tdameritrade.com, a Web platform for self-directed retail investors; Trade Architect, a Web platform for investors and traders to identify opportunities and stay informed; thinkorswim, a desktop platform for traders; and TD Ameritrade Mobile, which allows on-the-go investors and traders to trade and monitor accounts. It has a 33.23 P/E ratio. The firm also offers TD Ameritrade Institutional that provides brokerage and custody services to approximately 5,000 independent RIAs and their clients; TD Ameritrade's Goal Planning, which offers investment consulting and planning services; Investools, a suite of investor education services and products for stock, option, foreign exchange, futures, mutual fund, and fixed-income investors; Amerivest, an advisory service that develops portfolios of exchange-traded funds (ETFs) and mutual funds; AdvisorDirect, a national referral service for investors; and TD Ameritrade Corporate Services that provide self-directed brokerage services to employees of firms.

Since September 14, 2017, it had 1 insider buy, and 1 sale for $399.33 million activity. TD Luxembourg International Holdings S.a r.l. bought 11.07 million shares worth $400.00M. 15,000 shares valued at $669,900 were sold by MOGLIA JOSEPH H on Thursday, September 14.

The stock decreased 0.20% or $0.17 during the last trading session, reaching $86.79. About 693,352 shares traded or 58.22% up from the average. Hill-Rom Holdings, Inc. (HRC) has risen 57.47% since January 13, 2017 and is uptrending. It has outperformed by 40.77% the S&P500.

Since January 1, 0001, it had 0 insider buys, and 4 selling transactions for $19.24 million activity.

Ratings analysis reveals 100% of Hill-Rom’s analysts are positive. Out of 2 Wall Street analysts rating Hill-Rom, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $70.0 while the high is $70.0. The stock’s average target of $70 is -19.35% below today’s ($86.79) share price. HRC was included in 2 notes of analysts from January 24, 2017. Stifel Nicolaus initiated the shares of HRC in report on Tuesday, January 24 with “Buy” rating. Barclays Capital initiated the shares of HRC in report on Wednesday, February 8 with “Overweight” rating.

Copper Rock Capital Partners Llc holds 3.14% of its portfolio in Hill-Rom Holdings, Inc. for 640,661 shares. Bernzott Capital Advisors owns 257,788 shares or 2.72% of their US portfolio. Moreover, Malaga Cove Capital Llc has 1.75% invested in the company for 39,884 shares. The California-based Jasper Ridge Partners L.P. has invested 1.73% in the stock. Southernsun Asset Management Llc, a Tennessee-based fund reported 908,416 shares.

Analysts await Hill-Rom Holdings, Inc. (NYSE:HRC) to report earnings on January, 26. They expect $0.78 EPS, up 4.00% or $0.03 from last year’s $0.75 per share. HRC’s profit will be $51.34M for 27.82 P/E if the $0.78 EPS becomes a reality. After $1.32 actual EPS reported by Hill-Rom Holdings, Inc. for the previous quarter, Wall Street now forecasts -40.91% negative EPS growth.